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Abstract
In this paper, we extend the vertical modeling approach for the analysis of
survival data with competing risks to incorporate a cured fraction in the population,
that is, a proportion of the population for which none of the competing events can
occur. The proposed method has three components: the proportion of cure, the
risk of failure, irrespective of the cause, and the relative risk of a certain cause of
failure, given a failure occurred. Covariates may affect each of these components.
An appealing aspect of the method is that it is a natural extension to competing
risks of the semi-parametric mixture cure model in ordinary survival analysis; thus,
causes of failure are assigned only if a failure occurs. This contrasts with the existing
mixture cure model for competing risks of Larson and Dinse, which conditions at the
onset on the future status presumably attained. Regression parameter estimates are
obtained using an EM-algorithm. The performance of the estimators is evaluated
in a simulation study. The method is illustrated using a melanoma cancer data set.
1 Introduction
In medicine, the risk of failure from a given disease or the chance of getting cured of it are
of interest to the diseased patients as well as to the treating physicians; this helps patients
at risk to make important life decisions and it helps physicians in treatment selection.
However, investigating this type of information in a clinical study involving time-to-event
data requires accounting for multiple possible outcomes: either failure, due to the disease
or due to some other cause, or cure. From the statistical point of view, the analysis
of several types of failures is incorporated in the competing risks framework. These
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methods usually assume that all patients will eventually experience one of the possible
types of failure if there is sufficient follow-up and, therefore, do not accomodate cure. The
presence of cure is suggested when the data includes a considerable number of long-term
event-free survivors (censored patients with long follow-up times). Therefore, extending
modeling of competing risks to accommodate a cured proportion is an important issue in
understanding this type of data.
In the analysis of single outcome survival data with a cured fraction, cure models
address the problem of cure rate estimation, as well as the estimation of the probability of
failure due to the disease of interest. They have received a lot of attention both in terms of
methodological developments Farewell (1986); Sy and Taylor (2000); Li and Taylor (2002);
Yu et al. (2004); Kim et al. (2013) and applications Andersson et al. (2011); Andrae et al.
(2012). These cure models are mixture models which specify a conditional model for the
survival component, given that failure may occur, and a marginal distribution of the
binary indicator for whether or not cure can occur. They are formulated either in a
parametric or in a semi-parametric way (Kuk and Chen (1992); Taylor (1995); Sy and
Taylor (2000); Peng and Dear (2000); Peng (2003); Corbiere et al. (2009)). They share
the common feature of allowing the cure rate to be determined from the onset, but to
be observed only later in the course of the follow-up, leading to the presence of a sub-
population of event-free survivors beyond sufficiently long follow-up.
Analysis of competing risks data with a cure fraction is not well developed. Sev-
eral authors caste the competing risks model of Larson and Dinse (1985) into the cure
framework. These models express the mixing joint distribution of the time-to-event and
type of event variables as the sum of the marginal cause-specific distributions multiplied
by the associated mixing proportions. This approach is formulated under the strong,
unverifiable assumption that the mixing proportions for failure types and cure indicator
is determined but unobserved at the onset. In terms of formulas, this amounts to the
following decomposition of the joint distribution of time of failure T and failure type D:
(1) P (T,D) = P (T |D) · P (D).
Examples include the approach of Chao (1998), which imputes the cure indicator for
censored patients and uses a Gibbs sampling algorithm for estimation; Ng and McLachlan
(1998) propose a parametric version, to be used when there are only few failures from the
competing causes and Choi and Zhou (2002) discuss extensively a class of multivariate
parametric models. This approach could be adopted in contexts where the interest is in
assessing the parameters of the conditional failure time distribution given failure type or
in the mixing distribution of the different competing failure types.
However, from the inference and interpretation points of view, the case where the
model parameters translate directly into natural observable quantities in competing risks
is appealing. In this paper, we adopt this perspective and introduce a semi-parametric
approach for the analysis of competing risks data with a cure fraction. This approach
extends the idea of vertical modeling formulated earlier by Nicolaie et al. (2010) in the
competing risks framework, and it is based on the following decomposition of the joint
distribution of time of failure T and failure type D:
(2) P (T,D) = P (D|T ) · P (T ).
2
In the remainder of the article, we demonstrate how this can be applied to the analysis
of mixture cure data with several competing causes of failure in the presence of right-
censored data. In Section 2 we introduce in detail our approach. Simulation studies are
presented in Section 3. In Section 4 we illustrate our methods of analysis on a clinical
study on melanoma cancer. Section 5 concludes with some points for discussion.
2 Vertical modeling with a cured fraction
2.1 Notation
Suppose that data are available from n individuals each of whom can experience one
of J terminal, competing events during the period under study or can be subjected to
noninformative right censoring. Assume that a non-negligible proportion of individuals
does not experience any of the terminal events by the end of the follow-up and assume
further that follow-up is long enough to be able to consider individuals with full follow-
up as cured from the disease of interest on the basis of some clinical evidence. Such
population can naturally be regarded as a mixture population in which two categories of
individuals are combined: susceptible (the individual experiences failure, irrespective of
the cause) and non-susceptible or cured (the individual is immune to all causes of failure).
Let T˜ denote the time-to-event variable, C the right-censoring time variable, and D the
terminal event type, where D ∈ {1, . . . , J}. Assign D = 1 for the cause of interest and
D ≥ 2 for the competing causes. Let Z denote an l-vector of covariates measured at
baseline.
Consider a binary random variable Y such that Y = 1 corresponds to a susceptible
individual and Y = 0 corresponds to a nonsusceptible/cured individual. Note that in
this type of study Y is partially observed; it equals 1 in the case of an event, and it is
unobserved in the case of right-censoring. If the latter occurs, the individual has no event
observed during the study period, but either the event will eventually take place (the
individual is censored and susceptible) or the event will never take place in the future
(the individual is censored and non-susceptible).
The observed data for an individual i is Oi = (Ti,∆i, Zi), where Ti = min(T˜i, Ci) is
the earliest of time-to-event and censoring time, and ∆i = 1{T˜i < Ci}Di is the type of
terminal event in the case a terminal event occurs and 0 in the case of censoring, for
i = 1, . . . , n. Data from different individuals are assumed to be independent. Assume
that (T,D) and C are independent given Z.
2.2 Model formulation
Our goal is to develop and implement an approach to determine whether a terminal
event would occur (whether an individual is susceptible, which hereafter is referred to as
incidence) and, conditional on being susceptible, when the event might occur and which
type of event it might be, given a failure occurred (which hereafter are jointly referred to
as latency). In addition, we are interested in assessing covariate effects on incidence and
latency.
The incidence part is completely specified by the probability distribution P (Y ). De-
note P (Y = 1) = p; thus, 1 − p represents the proportion of individuals who get cured.
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For the latency part, we aim to extend the vertical modeling approach, earlier proposed
by Nicolaie et al. (2010), to the mixture cure model framework. We shall refer to this
competing risks mixture cure model as vertical modeling with a cured fraction (VMCF).
The main idea behind the modeling of the latency part of VMCF is to specify the
conditional (on Y = 1) joint distribution P (T,D|Y = 1) as
(3) P (T,D|Y = 1) = P (T |Y = 1) · P (D|T, Y = 1),
that is, the product of the conditional (on Y = 1) failure rate P (T |Y = 1) and of the
conditional distribution of the causes of failure, given a failure occurred P (D|T, Y = 1).
If we assume that the survival time T is continuous, we define the conditional (on Y = 1)
total hazard by
(4) λ•(t|Y = 1) = lim
∆t→0
P (t ≤ T ≤ t+ ∆t|T ≥ t, Y = 1)
∆t
and its cumulative counterpart by Λ•(t|Y = 1) =
∫ t
0
λ•(u|Y = 1)du. The former specifies
the conditional (on Y = 1) failure distribution P (T |Y = 1). In turn, the conditional
(on Y = 1) survival function of susceptible individuals, defined as S(t|Y = 1) = P (T >
t|Y = 1) is given by
(5) S(t|Y = 1) = exp(−Λ•(t|Y = 1)).
We emphasize that S(t|Y = 1) is a proper survival function in the sense that limt→∞ S(t|Y =
1) = 0. Note that the conditional (on Y = 0) survival function of non-susceptible is de-
generate, that is, P (T > t|Y = 0) = 1. We define the conditional (on Y = 1) relative
cause-specific hazard of cause j at time t by
(6) pij(t|Y = 1) = P (D = j|T˜ = t, Y = 1), j = 1, . . . , J.
Note that the probability pij(t|T˜ = t, Y = 1) deals with failure time and cause, therefore
its estimation involves only the (observed) susceptible individuals. This implies that (6)
can be expressed as:
(7) P (D = j|T˜ = t, Y = 1) = P (D = j|T˜ = t), j = 1, . . . , J.
As a consequence, we suppress the dependence on Y = 1 of pij(t|Y = 1) and, in the
following, we will denote it simply by pij(t). Thus the vector (pij(t))j=1,...,J denotes the
conditional (on T˜ = t) distribution P (D|T˜ = t), with Σjpij(t) = 1 for all t. Thus the
vector (λ•(t|Y = 1), (pij(t))j=1,...,J) completely specifies the latency part of VMCF.
The conditional (on Y = 1) cumulative incidence function of cause j, defined as
Fj(t|Y = 1) = P (T ≤ t,D = j|Y = 1), can be obtained as
(8) Fj(t|Y = 1) =
∫ t
0
λ•(u|Y = 1)pij(u)S(u− |Y = 1)du, j = 1, . . . , J.
The marginal survival function, which is defined as Spop(t) = P (T ≥ t) can be expressed
as
Spop(t) = P (Y = 1)P (T ≥ t|Y = 1) + P (Y = 0)P (T ≥ t|Y = 0)(9)
= p · S(t|Y = 1) + 1− p.
Note that Spop(t) is an improper survival function in the sense that limt→∞ Spop(t) = 1−p.
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2.3 Specific models
For the incidence p(X) = P (Y = 1|X), where X ⊆ Z, we postulate the usual binary
regression models:
(10) g(p(X)) = β>X∗,
where X∗ = (1,X), β stands for a vector of unknown regression parameters, including
an intercept, and g is a known differentiable link function. This includes the logistic link
model g(p) = log p
1−p , the complementary log-log link g(p) = log(− log(1 − p)) and the
probit link g(p) = Φ−1(p), where Φ−1 is the distribution function of a standard normal
distribution.
For the conditional (on Y = 1) total hazard we postulate a Cox proportional hazards
model:
(11) λ•(t|Y = 1,Z) = λ0(t|Y = 1) exp (γ>Z),
where λ0(·|Y = 1) is an unspecified conditional (on Y = 1) baseline hazard and γ stands
for a vector of unknown regression parameters. Let t0 = 0 and denote by t1 ≤ t2 ≤ . . . ≤
tK the K ordered event times. Assume that λ0(t|Y = 1) is a step function such that
λ0(t|Y = 1) = λ0(tl|Y = 1), all t ∈ [tl, tl+1)
for l ∈ {0, . . . , K − 1}.
For the relative hazards we specify
(12) pij(t|U) =
exp(κ>j B(t) + υ
>
j U)∑J
l=1 exp(κ
>
l B(t) + υ
>
l U)
, j = 1, . . . , J,
where U ⊆ Z, B(t) is an r-vector of pre-specified time functions and ηj = (κj, υj) stands
for an m-vector of unknown regression parameters, j = 1, . . . , J . For identifiability, we
set ηJ ≡ 0. Examples of B(t) are polynomial or spline functions. Denote by θ the vector
(β,γ, η1, . . . , ηJ) of all regression parameters characterizing the components of VMCF.
2.4 Marginal model
It is also interesting to look at the relationship between the marginal (population) total
hazard λ•,pop(t) and the conditional (on Y = 1) total hazard λ•(t|Y = 1). First, note
that the conditional expectation of Y given T ≥ t is determined by
(13)
E[Y |T ≥ t] = P (Y = 1|T ≥ t) = P (Y = 1)P (T ≥ t|Y = 1)
P (T ≥ t) =
p · S(t|Y = 1)
pS(t|Y = 1) + 1− p.
The marginal total hazard is given by
(14) λ•,pop(t) =
−S ′pop(t)
Spop(t)
=
pS(t|Y = 1)λ•(t|Y = 1)
pS(t|Y = 1) + 1− p = E[Y |T ≥ t]λ•(t|Y = 1),
where S
′
stands for the derivative of S. Intuitively, the above relationship between the
two hazards expresses the fact that λ•,pop(t) is the average of the Y λ•(t|Y = 1) taken
over all the individuals at risk just before T = t.
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Note that (11) implies that the marginal total hazard is given by
(15)
λ•,pop(t|Z,X) = λ0(t|Y = 1) exp (γ>Z) g
−1(β>X∗)S0(t|Y = 1)exp (γ>Z)
g−1(β>X∗)S0(t|Y = 1)exp (γ>Z) + 1− g−1(β>X∗) ,
where S0(t|Y = 1) = exp(−Λ0(t|Y = 1)). This clearly shows that at the population level,
the proportional hazards assumption postulated in the strata {Y = 1} no longer holds.
Alternatively, we can write the model in the following way:
(16) λ•,pop(t|Z) = λ0(t) exp (η>(t)Z) ,
where λ0(t) is an unspecified baseline hazard and η(t) is an unknown, time-dependent
vector of regression coefficients. For two individuals with covariate vectors Z and Z˜, the
following relationship holds for the k-th component of the vector η(t):
(17) ηk(t)(Zk − Z˜k) = γk(Zk − Z˜k) + log E[Y |T ≥ t,Z,X]
E[Y |T ≥ t, Z˜, X˜]
,
which expresses that the log hazard ratio at the population level equals the sum of the
log hazard ratio in the strata {Y = 1} and of a time-varying term. Derivation of this
formula is given in Appendix A.
2.5 Likelihood
Omitting covariates for a moment, the observed likelihood is the product of contributions
of individuals from two categories: an individual i who fails at time ti due to cause j
contributes
P (T˜i = ti, Di = j, Yi = 1) = P (Yi = 1) · P (T˜ = ti|Yi = 1) · P (Di = j|T˜i = ti) · P (Ci > ti),
and an individual i who is censored at time ti contributes
P (T˜ > ti) =
[
P (Yi = 1) · P (T˜ > ti|Yi = 1) + P (Yi = 0)
] · P (Ci = ti).
If we assume that the distributions of T and C have no common parameters, then
we can omit the contribution of C to the likelihood; therefore, the observed likelihood is
proportional to
L =
n∏
i=1
[
piP (T˜ = ti|Yi = 1)
J∏
j=1
P (Di = j|T˜i = ti)1{Di=j}
]1{Di>0}
·
n∏
i=1
[
piP (T˜ > ti|Yi = 1) + (1− pi)
]1{Di=0}.
In terms of relative and (conditional) total hazards, the observed likelihood can be written
as
L =
n∏
i=1
{
piλ•(ti|Yi = 1) exp [−Λ•(ti|Yi = 1)]
J∏
j=1
pij(ti)
1{Di=j}
}1{Di>0}
·
n∏
i=1
{
pi exp [−Λ•(ti|Yi = 1)] + (1− pi)
}1{Di=0}
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which can be separated in the following way:
(18) L(θ, λ0(t|Y = 1)) = L1(β,γ, λ0(t|Y = 1);Y ) · L2(η1, . . . , ηJ),
where
L1(β,γ, λ0(t|Y = 1);Y ) =
n∏
i=1
{
piλ•(ti|Yi = 1) exp [−Λ•(ti|Yi = 1)]
}1{Di>0}
·
n∏
i=1
{
pi exp [−Λ•(ti|Yi = 1)] + (1− pi)
}1{Di=0}
and
L2(η1, . . . , ηJ) =
n∏
i=1
J∏
j=1
pij(ti)
1{Di=j}.
2.6 Estimation
We will use a variant of the EM algorithm given in Sy and Taylor (2000) to estimate the
parameters (θ, λ0(t1|Y = 1), . . . , λ0(tK |Y = 1)) of the VMCF. The technique consists of
an adaptation of the EM algorithm to deal with the latent Y and to accommodate our
semi-parametric approach. Typically, it is assumed that all event-free survivors after tK
get cured. This amounts to imposing the zero-tail constraint, that is, S(t|Y = 1) = 0 for
t ≥ tK , a condition which assures that the observed likelihood is well-behaved (see also
Sy and Taylor (2000)).
Denote by C the complete data, that is, the sample data when the latent Y would be
observed for all cases. The complete likelihood function is given by:
LC(θ, λ0(t|Y = 1)) = L3(β,γ, λ0(t|Y = 1);Y ) · L2(η1, . . . , ηJ),
where
L3(β,γ, λ0(t|Y = 1);Y ) =
n∏
i=1
{
piλ•(ti|Yi = 1) exp [−Λ•(ti|Yi = 1)]
}1{Di>0}
·
n∏
i=1
{{
pi exp [−Λ•(ti|Yi = 1)]
}1{Yi=1} · (1− pi)1{Yi=0}}1{Di=0}.
Note that Di > 0 implies Yi = 1, and Yi = 0 implies Di = 0. After rearranging the
factors, we get:
L3(β,γ, λ0(t|Y = 1);Y ) =
n∏
i=1
p
1{Yi=1}
i (1− pi)1{Yi=0}
·
n∏
i=1
λ•(ti|Yi = 1)1{Di>0} exp [−YiΛ•(ti|Yi = 1)](19)
= L31(β;Y ) · L32(γ, λ0(t|Y = 1);Y ).
7
The maximization of logLC(θ, λ0(t|Y = 1)) is enhanced by the observation that the
multinomial logistic structure embedded in logL2(η1, . . . , ηJ) can be maximized indepen-
dently of logL3(β,γ, λ0(t|Y = 1);Y ). An appealing fact is that this can be achieved by
means of standard software like the PROC GLM in SAS or the glm function in R (R
Development Core Team (2010)). Denote by (η̂1, . . . , η̂J) the estimator of (η1, . . . , ηJ).
Maximization of logL3(β,γ, λ0(t|Y = 1);Y ) is more involved and uses the EM-algorithm
following the approach in Sy and Taylor (2000). Technical details are given in Appendix
B.
2.7 Standard errors
An approximation of the asymptotic variance of (θ, λ0(t1|Y = 1), . . . , λ0(tK |Y = 1))
can be obtained as the inverse of the observed full information matrix =θ,λ0(t|Y=1) of
L(θ, λ0(t|Y = 1)). Note that due to the factorisation (18), we can write:
=θ,λ0(t|Y=1) =
 =β,γ,λ0(t|Y=1) | 0− | −
0 | =η

where =β,γ,λ•(t|Y=1) is the observed full information matrix of L1(β,γ, λ0(t|Y = 1);Y )
and =η is the observed full information matrix of L2(η1, . . . ,ηJ).
Sy and Taylor (2000) derived a formula for =β,γ,λ•(·|Y=1). In Appendix C, we use
their results to obtain the standard errors of the conditional (on Y = 1) cause-specific
cumulative hazards from vertical modeling with a cure fraction.
3 Simulations
In this simulation study, we assess the performance of our estimators in the semi-parametric
setting when the assumed model is correct. We simulate data for n = 500 individuals,
each of whom can fail due to the disease (cause 1) or due to a competing cause (cause
2), or can be subjected to right-censoring. Assume a non-negligible proportion of indi-
viduals get cured. Individuals are followed over a period of at most 15 years; random
right-censoring, which is independent of survival time, occurred uniformly in the interval
[7, 15] years. Assume Z ∼ N(0, 1) is a continuous, normally distributed baseline co-
variate. We generate data as random samples drawn from a VMCF model (the “true”
model), where we assume that the cure indicator Y follows a logistic regression model:
logit(P (Y = 1|Z)) = β0 + β1 · Z,
for (β0, β1) ∈ {(−0.62, 1.24), (−1.38, 0), (1.38, 0)} leading to three scenarios with various
amounts of cure proportions, that is, 65% for Z = 1, 80% and 20% respectively. The
latency part is specified by
λ•(t|Y = 1, Z) = λ0(t|Y = 1) exp (γZ),
where γ = 0.3 and the baseline hazard λ0(t|Y = 1) is constant, equal to 0.4. The relative
hazards are constant such that pi1(t) = 0.25 and pi2(t) = 0.75, favoring cause 2 over cause
1.
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VMCF and VM are fitted to the simulated data. The incidence component of VMCF
and the conditional (on Y = 1) total hazard are assumed to have the same form as in
the true model. The relative hazards are assumed constant over time, with no covariate
effect; the observed proportions of cause specific events relative to the total number of
events were employed as their estimates. The covariate Z was therefore included in the
two mixture components (incidence and latency). The probabilities F̂j(t|Yi = 1, Zi) and
F̂j(t|Zi), j = 1, 2, are reported at each of the prediction time points {1, 2, 5, 7, 11} for an
individual i with Zi = 1. In VM, a Cox proportional hazards model with Z as predictor
with unspecified baseline hazard is postulated for the total hazard. The relative hazards
are identical with those in VMCF. The probabilities F̂j(t|Zi), j = 1, 2, are reported at
each of the prediction time points {1, 2, 5, 7, 11} for an individual i with Zi = 1.
We reported in Tables 1 and 2 the estimated bias and root mean squared error (RMSE)
obtained for our estimators under various proportions of susceptibles. Each scenario was
run 10000 times.
Table 1: Estimated bias (root mean squared error) F̂j(t|Y = 1, Z = 1) with respect to the
true cumulative incidence function Fj(t|Y = 1, Z = 1), j = 1, 2, for the three scenarios.
65% cure in {Z = 1} 80% cure 20% cure
t F̂1(t|Y = 1, Z = 1) F̂2(t|Y = 1, Z = 1) F̂1(t|Y = 1, Z = 1) F̂2(t|Y = 1, Z = 1) F̂1(t|Y = 1, Z = 1) F̂2(t|Y = 1, Z = 1)
1 -0.0001 (0.0162) -0.0005 (0.0314) -0.0003 (0.0239) -0.0008 (0.0500) -0.0004 (0.0119) -0.0012 (0.0247)
2 0.0001 (0.0229) 0.0003 (0.0350) 0.0000 (0.0328) 0.0002 (0.0559) -0.0002 (0.0164) -0.0006 (0.0276)
5 0.0012 (0.0302) 0.0036 (0.0337) 0.0018 (0.0419) 0.0057 (0.0495) 0.0004 (0.0208) 0.0015 (0.0240)
7 0.0017 (0.0313) 0.0052 (0.0335) 0.0030 (0.0435) 0.0092 (0.0472) 0.0008 (0.0215) 0.0027 (0.0228)
10 0.0029 (0.0321) 0.0088 (0.0339) 0.0049 (0.0447) 0.0151 (0.0476) 0.0013 (0.0219) 0.0041 (0.0225)
Table 2: Estimated bias (root mean squared error) of F̂j(t|Z = 1) with respect to the
true cumulative incidence function Fj(t|Z = 1), j = 1, 2, in VM and VMCF respectively,
when β0 = −0.62, β1 = 1.24 and γ = 0.3.
VM VMCF
t F̂1(t|Z = 1) F̂2(t|Z = 1) F̂1(t|Z = 1) F̂2(t|Z = 1)
1 -0.0064 (0.0119) -0.0193 (0.0284) 0.0000 (0.0112) 0.0002 (0.0229)
2 -0.0086 (0.0170) -0.0260 (0.0366) 0.0004 (0.0160) 0.0012 (0.0281)
5 -0.0084 (0.0217) -0.0254 (0.0393) 0.0012 (0.0214) 0.0037 (0.0322)
7 -0.0071 (0.0221) -0.0214 (0.0376) 0.0016 (0.0222) 0.0049 (0.0330)
10 -0.0053 (0.0222) -0.0159 (0.0353) 0.0024 (0.0228) 0.0073 (0.0338)
The proposed method of estimation VMCF shows little bias in estimating both
F̂j(t|Y = 1, Z = 1) and F̂j(t|Z = 1), with bias (RMSE) increasing with the increase
in the cure proportion. The bias contributes little to the RMSE. The behaviour at later
time points is more uncertain due to the smaller number of events by the end of the follow
up. Comparisons of F̂j(t|Z = 1) derived from VMCF and VM with the true cause-specific
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cumulative incidences consistently show smaller bias (RMSE) for VMCF, thus supporting
the idea that fitting VMCF to data from a population with a non-neglijable proportion
of cure can replace a conventional survival model when the interest is to estimate the
disease frequency.
The coverage rates for the normal approximations 95% confidence intervals of F̂j(t|Y =
1, Z = 1) and F̂j(t|Z = 1) are higher for VMCF compared to VM. They are reported in
Table 3 for the first scenario. The other two scenarios, with heavy or small amount of
cure, show the same pattern (not reported).
Table 3: Estimated coverage probabilities of F̂j(t|Y = 1, Z = 1) and F̂j(t|Z = 1), j = 1, 2
in VM and VMCF respectively, when β0 = −0.62, β1 = 1.24 and γ = 0.3.
VMCF VM VMCF
t F̂1(t|Y = 1, Z = 1) F̂2(t|Y = 1, Z = 1) F̂1(t|Z = 1) F̂2(t|Z = 1) F̂1(t|Z = 1) F̂2(t|Z = 1)
1 95.2 95.4 90.8 85.1 95.2 95.5
2 95.1 95.1 91.6 82.9 95.0 95.0
5 95.1 95.1 93.3 86.8 95.1 95.2
7 95.2 95.0 94.2 89.9 95.1 94.8
10 95.1 94.4 94.8 92.5 95.1 94.6
The performance of estimators β̂0, β̂1 and γ̂ was studied in Sy and Taylor (2000).
Since these parameters are separated from the parameters of the relative hazards model,
the results obtained in Sy and Taylor (2000) are applicable to and were confirmed in our
setting and consequently have not been explored further.
4 Data analysis
Our data comprises 205 patients with malignant melanoma who had their tumor removed
by surgery between 1962 and 1977. These data from Andersen et al. (1993) are part of
the boot package (Canty and Ripley (2008)) for the R software. This was a prospective
clinical study to assess the effect of risk factors on survival. Baseline covariates are
gender, age (in years) at operation, year of operation, tumor thickness and ulceration of
the tumor tissue. Age (scaled by 10), year of operation (centered at 1970 and scaled by
10) and thickness were considered continuous covariates; age ranged from 4 to 95 years
and thickness ranged from 0.10 to 17.42 mm. 61% of patients were men and 44% of
patients presented with ulceration of the tissue at the time of surgery. The follow-up
time ranged from 10 days to 15.23 years. The survival time is known only for those
patients who have had their event before the end of 1977. The rest of the patients are
censored at the end of 1977. Endpoint of interest is the time from operation to death due
to melanoma (cause 1), in the presence of a competing cause, that is, death due to other
causes, unrelated to melanoma (cause 2). The total number of deaths was 71: 57 (80%)
deaths due to cause 1 and 14 (20%) deaths due to cause 2. Of the 134 censored patients,
27 were censored with longer follow-up time than the largest death time. Figure 1 shows
the Kaplan-Meier estimate of the survival function of time to any terminal event. This
10
0 5 10 15
0.0
0.2
0.4
0.6
0.8
1.0
Years since surgery
Su
rv
iv
in
g 
fra
ct
io
n
Kaplan−Meier estimate of overall survival
Figure 1: The estimated Kaplan-Meier curve of time to all-causes failure.
survival curve appears to reach a plateau 10 years post-surgery, indicating the presence
of a sub-population which survives event-free by the end of the follow-up and clearly
suggesting the appropriateness of a competing risks mixture cure model. For these data
clinical interest is to understand how covariates affect the survival distribution, after
surgery for melanoma, in the presence of competing risks.
First a vertical model ignoring cure (VM) was fit to the data. This model serves
two purposes: (1) to estimate the effect of covariates on time to death due to each of
melanoma cancer and other causes and (2) to estimate the probabilities of each type of
events since surgery. The model aggregates the covariate effects on latency and incidence
in an intricate way (see, for instance, equation (15)). A Cox proportional hazards model
was used for the total hazard including all covariates:
λ•(t|Z) = λ0(t) exp (γ>Z),
where λ0(·) is an unspecified baseline hazard and γ stands for a vector of unknown
regression parameters, and a logistic regression model was used for the relative hazards
including all covariates and piecewise constant time functions, with cut-off points at the
0.25, 0.5, 0.75 quartiles of the failure time distribution leading to:
(20) logit(pi1(t|T˜ = t,Z)) = κ>1 B(t) + υ>1 Z,
where B(t) = (1{t ∈ (0, 1.76]},1{t ∈ (1.76, 2.90]},1{t ∈ (2.90, 4.67]},1{t ∈ (4.67, 15.23]})
and η1 = (κ1, υ1) stands for a vector of unknown regression parameters. The estimated
regression parameters are reported in Table 4.
For illustration, we present the results of the model fit for a male patient with ulcer-
ation and for average values of the continuous covariates. Table 5 gives the estimated
relative hazards implied by fitting model (20) with associated standard errors. It can be
seen that the dominating cause of death post surgery is melanoma cancer.
Figure 2 shows (in gray lines) the estimated cumulative incidence functions of time
to type 1-event and time to type 2-event.
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Table 4: Regression parameters in VM.
Covariate Regression parameters (SE) Regression parameters (SE)
in Cox model for survival in logistic model for relative hazard
Thickness 0.09 (0.04) 0.01 (0.12)
Ulcer 0.98 (0.26) 1.46 (0.86)
Age 0.02 (0.08) -0.04 (0.24)
Year (stand) -0.88 (0.55) -0.95 (1.70)
Sex 0.42 (0.24) 0.30 (0.72)
1{t ∈ (0, 1.76]} 1.93 (1.87)
1{t ∈ (1.76, 2.90]} 4.24 (2.08)
1{t ∈ (2.90, 4.67]} 3.84 (1.80)
1{t ∈ (4.67, 15.23]} 2.61 (1.67)
Table 5: Estimated piecewise constant relative hazards of cause 1 and their standard error
for a male patient with ulceration and for average values of the continuous covariates
derived by fitting VM.
(0, 1.76] (1.76, 2.90] (2.90, 4.67] (4.67, 15.23]
Cause 1 0.754 (0.141) 0.968 (0.038) 0.954 (0.044) 0.858 (0.106)
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Figure 2: The estimated cumulative incidences of time to melanoma and time to other
causes based on VM (in gray) and on VMCF (in black) for a male individual with
ulceration and for the mean values of the continuous covariates, together with the 95%
confidence intervals derived by fitting the former model.
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Table 6: Regression parameters in VMCF.
Regression parameters (SE)
Covariate Incidence model Latency model
Conditional Cox Logistic
Intercept -2.62 (0.88)
Thickness 0.07 (0.11) 0.10 (0.06) 0.01 (0.12)
Ulcer 0.95 (0.64) 0.87 (0.50) 1.46 (0.86)
Age 0.03 (0.15) -0.0006 (0.11) -0.04 (0.24)
Year(stand) 0.51 (0.89) -1.49 (1.03) -0.95 (1.70)
Sex 0.57 (0.47) 0.42 (0.50) 0.30 (0.72)
1{t ∈ (0, 1.76]} 1.93 (1.87)
1{t ∈ (1.76, 2.90]} 4.24 (2.08)
1{t ∈ (2.90, 4.67]} 3.84 (1.80)
1{t ∈ (4.67, 15.23]} 2.61 (1.67)
We then applied the vertical modeling with a cured fraction (VMCF) to these data.
This model serves three purposes: (1) to estimate the effect of covariates on time to death
due to each of melanoma cancer and other causes in the population of uncured patients,
(2) to estimate the cause-specific cumulative incidences in the population of uncured
patients and (3) to estimate the effect of covariates on the probability of being cured.
A logistic regression model was postulated for the incidence part and for the latency
part, a Cox proportional hazards model for the conditional (on Y = 1) total hazard and
a logistic model for the relative hazards where piece-wise constant time functions were
used with cut-off points at the quartiles of the failure time distribution function. Note
that this model for the relative hazards coincides with the one used in VM where the
evidence of cure was ignored, because the conditional (on T = t) distribution of causes of
failure depends only on the actual causes of failure observed. All baseline covariates were
included in both parts (incidence and latency) of the model. No selection of covariates was
performed to test whether some covariates could be removed. The estimated regression
parameters are reported in Table 6.
The estimators of the survival curve Spop(t|Z) and of the conditional (on Y = 1) sur-
vival curve S(t|Y = 1,Z), for a male individual with ulceration and for average values of
the continuous covariates, are plotted in Figure 3 in dashed and dotted lines, respectively,
and compared with the estimator of the survival curve S(t|Z) derived from VM (solid
line).
The estimated conditional (on Y = 1) cumulative incidence function for a susceptible
male patient with ulceration and for the mean values of the continuous covariates are
plotted in Figure 4. The corresponding predicted probability of cure is 1− p̂ = 0.25. We
also plotted in Figure 2 (in black) the estimated (unconditional) cumulative incidence
functions of time to melanoma and time to other causes derived from VMCF, for a male
individual with ulceration and average values of his other covariates. As expected in
Figure 3, the estimates for the population Spop(t|Z) based on our VMCF model is similar
to that based on VM.
Finally, it is worth comparing Table 4 with Table 6; it clearly shows that, especially
for age, interpretation in terms of hazard ratios differs between S(t|Y = 1,Z) and S(t|Z).
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Figure 3: The estimated survival curve of time to any event at the mean values of the
continuous covariates for a male individual with ulceration, based on VM (solid line)
and on VMCF for the combined population (dashed line) and for the susceptible sub-
population (dotted line), together with the 95% confidence intervals derived by fitting
the former model.
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Figure 4: Model-based estimates of the conditional (on Y = 1) cumulative incidences of
time to melanoma and time to other causes for susceptible male patient with ulceration
and for the mean values of the continuous covariates.
14
5 Discussion
Little has been published about cure models in combination with competing risks. Several
reviews have been recently published to highlight the advantages of cure models over the
limitations of standard methods like Kaplan-Meier, Cox models or parametric models
for survival data when statistical cure is a reasonable assumption (Jia et al. (2013); Yu
et al. (2013)). In this paper, we have illustrated a strategy for the statistical analysis of
competing risks data with a cure fraction. In this way, we have argued that, when there
is clinical evidence of a cured proportion in a cohort, special attention should be given to
the heterogeneity present among individuals.
An important advantage of the competing risks mixture cure model (VMCF) over
the standard competing risks model (VM) is two-fold: (1) it allows inference of the
susceptible sub-population, and therefore a better understanding and interpretation of
the variability of the data and (2) it allows estimation and direct modeling of the cure
indicator. Summary measures like these can be a useful tool to complement the existing
statistical measures. Each covariate in VMCF can contribute with up to three sets of
regression parameters, one parameter reflecting how the covariate affects the chance of
cure, one parameter for the risk of failure, irrespective of the cause of failure, and one set
of parameters for the relative position of each failure type among all failure types.
An appealing technical feature of VMCF resides in its parametrisation, which is il-
lustrated in equation (18). VMCF naturally separates the observed likelihood into two
factors: one where the cure indicator distribution is irrelevant and one where the cure
indicator distribution is relevant. The former factor is pertinent to causes of failure when
a failure occurs; in the absence of competing events, the observed likelihood (18) re-
duces to the observed likelihood of the Cox proportional hazards mixture cure model of
Sy and Taylor (2000). The latter factor uses information on the failure and censoring
times and, therefore, it is sensitive to the joint distribution of (T, Y ). This feature makes
our method straighforward to implement by means of smcure package available in R
Development Core Team (2010).
We believe that our approach can play a useful role, as it can accommodate complex
competing risks data. It is worth mentioning that the approach can be naturally extended
to deal with missing causes of failure in competing risks. We refer to the work of Nicolaie
et al. (2011) for a description of how this can be achieved.
An important issue is that semi-parametric mixture cure models are by construction
non-identifiable. We cannot precisely tell apart individuals who are cured or not among
those who are censored. However, the presence of individuals with long follow-up and
event-free works as empirical evidence of the existence of a cured subgroup. We adopt the
strategy of Sy and Taylor (2000), who approach the non-identifiability problem through
the use of the zero-tail constraint on the baseline failure time distribution. Another
strategy has been adopted by Peng (2003), who impose a parametric shape on the tail of
the failure time distribution.
Another aspect goes to the core of how cure is perceived in the presence of competing
risks, other than the risk that is related to the disease. It might be the case that a diseased
patient is at risk of several mutually exclusive causes of failure and their potential cure
from the disease cannot be observed if they die from accidental causes. For instance, a
different formulation is proposed by Basu and Tiwari (2010), where separate competing
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risks structures are considered for the cure and the susceptible latent groups and a joint
prior distribution is assumed on the collection of parameters. Cure is defined as not
having experienced death due to the disease-related cause; therefore, the status of cure
is observed only for individuals subjected to death not due to the cause of interest. We
are currently adapting the vertical modeling approach to this situation.
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Appendix A: Derivation of formula (17)
Using (16), the hazard ratio corresponding to two individuals with covariate values given
by Z and Z˜ is given by
λ•,pop(t|Z)
λ•,pop(t|Z˜)
= eη
>(t)(Z−Z˜).
On the other hand, using (15), the same hazard ratio is given by
λ•,pop(t|Z,X)
λ•,pop(t|Z˜, X˜)
= eγ
>(Z−Z˜) · E[Y |T ≥ t,Z,X]
E[Y |T ≥ t, Z˜, X˜]
,
Equating the two representations leads to
η>(t)(Z− Z˜) = γ>(Z− Z˜) + log E[Y |T ≥ t,Z,X]
E[Y |T ≥ t, Z˜, X˜]
whose k-th component is given by (17).
Appendix B: The EM-algorithm
In the E-step of the algorithm the conditional expectation of logL3(β,γ, λ0(t|Y = 1);Y )
is computed with respect to the distribution of the unobserved Yi’s, given the current
parameters values and the observed data O = (Oi)i=1,...,n. As Yi’s contribute as linear
terms in logL3(β,γ, λ0(t|Y = 1);Y ), it is enough to compute, at a given iteration m,
the weight w
(m)
i = E(Yi|θ(m), λ(m)0 (t|Y = 1),O). For an individual i who experiences an
event at time ti (irrespective of its cause) the corresponding weight is
w
(m)
i = E(Y |θ(m), λ(m)0 (ti|Y = 1), T = ti, Di ∈ {1, . . . , J})
= P (Yi = 1|θ(m), λ(m)0 (ti|Y = 1), T = ti, Di ∈ {1, . . . , J})
= 1,
while for an individual i who is censored at time ti the corresponding weight is
w
(m)
i = E(Y |θ(m), λ(m)0 (ti|Y = 1), T > ti, Di = 0)
= P (Yi = 1|θ(m), λ(m)0 (ti|Y = 1), T > ti, Di = 0)
=
g−1(β>X∗i ) · S0(ti|Y = 1)exp(γ>Zi)
g−1(β>X∗i ) · S0(ti|Y = 1)exp(γ>Zi) + 1− g−1(β>X∗i )
∣∣∣∣∣
(θ,λ0(ti|Y=1))=(θ(m),λ(m)0 (ti|Y=1))
.
Denote the expected complete log-likelihood by Ep[logL3(β,γ, λ0(ti|Y = 1);w(m))|O],
where w(m) = (w
(m)
i )i=1,...,n.
In the M -step of the algorithm, Ep[logL3(β,γ, λ0(t|Y = 1);w(m))|O] is maximized
with respect to (β,γ, λ0(t|Y = 1), given w(m). Unlike in the standard Cox proportional
hazards model, where the baseline hazard is seen as a nuisance parameter and eliminated
in the procedure of estimating γ, one cannot eliminate λ0(t|Y = 1) in the Cox propor-
tional hazards model embedded in the VMCF without loosing information about β. The
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main reason is that the hazard rate at the population level is no longer proportional
(see (15) and (16)) and arguments similar to those leading to the Cox partial likelihood
do not hold true anymore. Peng and Dear (2000), Sy and Taylor (2000) proposed a
partial likelihood type method to estimate γ without specifying the nuisance parameter
Λ0(t|Y = 1). This involves the updating of the Aalen-Nelson estimator of Λ0(t|Y = 1) at
the mth iteration as given by
Λ̂0(t|Y = 1) =
∑
i:ti≤t
di∑
l∈Ri w
(m)
l exp(γ̂
>Zl)
,
where di is the number of events at time ti, irrespective of the cause, and Ri is the risk set
at ti. By substituting Λ̂0(t|Y = 1) into logL32(γ, λ0(t|Y = 1);w(m)) we get the weighted
partial likelihood of γ, that is
n∏
i=1
[ exp(γ>Zi)∑
l∈Ri w
(m)
l exp(γ
>Zl)
]1{Di>0}
.
To assure identifiability, we impose the zero-tail constraint (see Sy and Taylor (2000)),
that is, Ŝ0(t|Y = 1) = 0 for t > tK .
Appendix C: The standard errors of conditional (on
Y = 1) cumulative hazards from vertical modeling with
a cure fraction
In this appendix we derive the formula for the standard error of the conditional (on Y = 1)
cause-specific cumulative hazard from vertical modeling with a cure fraction, when we
omit the vector Z of covariates from the model of the latency component. As a conse-
quence, the vector of parameter describing VMCF is (β,η, λ•(t1|Y = 1), . . . , λ•(tK |Y =
1)).
The Nelson-Aalen estimator of Λ•(t|Y = 1), denoted by Λ̂•(t|Y = 1), makes jumps
of size dΛ̂•(t|Y = 1) at event time points 0 = t0 ≤ t1 < t2 < . . . < tK < ∞. An
approximation of the covariance matrix of (β, dΛ̂•(t1|Y = 1), . . . , dΛ̂•(tK |Y = 1)) is
given by the inverse of the observed full information matrix =β,dΛ̂•(·|Y=1).
Remark. The matrix =β,dΛ̂•(·|Y=1) is not diagonal. Let Ξβ,dΛ̂•(·|Y=1) denote an inverse
of =β,dΛ̂•(·|Y=1) and let ΞdΛ̂•(·|Y=1) be the sub-matrix of Ξβ,dΛ̂•(·|Y=1) corresponding to
dΛ̂•(·|Y = 1).
Relevant quantities for our purposes are the relative hazards pij(t); we model them as
in formula (12).
Remark. Often it will convenient to retain the system (12) and to work with the r×J
Fisher information matrix of η> =
(
η1, . . . , ηJ
)>
, denoted by =η which has rank r(J − 1)
and, in particular, is not invertible. Let Ξη denote a Moore-Penrose generalized inverse
of =η.
We are interested to develop a formula for the JK×JK covariance matrix var(Λ̂(·|Y =
1)) =: ΞΛ of the estimator Λ̂j(t|Y = 1) =
∑
ts≤t pij(ts)λ̂•(ts|Y = 1) =
∑
ts≤t λ̂js,Y=1,
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where λ̂js,Y=1 = pij(ts)λ̂•(ts|Y = 1). First, we introduce some notation, as follows:
τ = (η, λ•(t1|Y = 1), . . . , λ•(tK |Y = 1))> ,
Λ =
(
(Λj(t1|Y = 1))j=1,...,J , (Λj(t2|Y = 1))j=1,...,J , . . . , (Λj(tK |Y = 1))j=1,...,J
)>
and
λ =
(
λ11,Y=1, λ21,Y=1, . . . , λJ1,Y=1, λ12,Y=1, . . . , λJ2,Y=1, λ1K,Y=1, . . . , λJK,Y=1
)
.
According to the Delta-method, we get
(21) ΞΛ =
∂Λ(·|Y = 1)
∂λ(·|Y = 1) ·
∂λ(·|Y = 1)
∂τ
· var(τ̂ ) ·
(∂Λ(·|Y = 1)
∂λ(·|Y = 1) ·
∂λ(·|Y = 1)
∂τ
)>
.
It is straightforward to see that the matrix ∂Λ
∂λ
of order JK is given by
(22)
∂Λ
∂λ
=

IJ×J 0 0 0
IJ×J IJ×J 0 0
. . . . . .
. . . . . .
. . . 0
IJ×J IJ×J . . . IJ×J

where IJ×J is the identity matrix of order J . Also, we have
∂λjs,Y=1
∂ηlu
= −pij(ts)pil(ts)λ•(ts|Y = 1)Bu(ts) ,
where j, l ∈ {1, . . . , J}, j 6= l, s ∈ {1, . . . , K}, u ∈ {1, . . . , r}, and
∂λjs,Y=1
∂ηju
= pij(ts)
[
1− pij(ts)
]
λ•(ts|Y = 1)Bu(ts) ,
where j ∈ {1, . . . , J}, s ∈ {1, . . . , K}, u ∈ {1, . . . , r}.
Moreover,
∂λjs,Y=1
∂λ•(tv|Y = 1) = pij(ts)δs,v ,
where j ∈ {1, . . . , J}, s, v ∈ {1, . . . , K} and δ stands for the Kronecker delta.
We shall define, for t ≥ 0, the J × J matrix Ω(t) as follows:
Ω(t) =

pi1(t) 0 . . . 0
0 pi2(t) . . . 0
. . . . . . . . . . . .
0 0 . . . piJ(t)
− (pi1(t), pi2(t), . . . , piJ(t))>(pi1(t), pi2(t), . . . , piJ(t)) ,
and the r-vector
α(t) =
(
λ•(t|Y = 1)B1(t), λ•(t|Y = 1)B2(t), . . . , λ•(t|Y = 1)Br(t)
)>
.
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Setting
Π(ts) =
(
pi1(ts), pi2(ts), . . . , piJ(ts)
)>
,
a column vector of length J , for s ∈ {1, . . . , K}, we get
(23)
∂(λ1s,Y=1, λ2s,Y=1, . . . , λJs,Y=1)
∂(η1, η2, . . . , ηJ)
= Ω(ts)⊗ (α(ts))>, s ∈ {1, . . . , K} ,
where ⊗ stands for the Kronecker product, and finally
(24)
∂λ
∂τ
=

Ω(t1)⊗ (α(t1))> Π(t1) 0 0 0
Ω(t2)⊗ (α(t2))> 0 Π(t2) 0 0
0
. . . . . .
...
...
. . . . . . . . .
. . . . . . 0
Ω(tK)⊗ (α(tK))> 0 0 0 . . . 0 Π(tK)

which is a matrix of order JK × (Jr +K). As a result, we obtain
(25) Ξλ =
∂λ
∂τ
 Ξη | 0− | −
0 | ΞdΛ̂•(·|Y=1)
(∂λ
∂τ
)>
.
In conclusion, using (21), (22) and (25), we have that
(26) ΞΛ =

W1ΞηW1 + Π˜1 W1ΞηW2 + Π˜1 . . . W1ΞηWK + Π˜1
W2ΞηW1 + Π˜1 W2ΞηW2 + Π˜2 . . . W2ΞηWK + Π˜2
...
...
. . .
...
WKΞηW1 + Π˜1 WKΞηW2 + Π˜2 . . . WKΞηWK + Π˜K
 ,
where
Wk =
k∑
s=1
Ω(ts)⊗ (α(ts))>, k ∈ {1, . . . , K} ,
and
Π˜kl =
k∑
l=1
ΞdΛ̂•(·|Y=1) ⊗
( k∑
s=1
Π(ts)(Π(tl))
>), k, l ∈ {1, . . . , K} .
21
